ANGPTL8 and metabolic dysfunction-associated steatotic liver disease: Serum ANGPTL8 levels are significantly higher (p = 0.035) in NAFLD patients (279.1 ± 118.6 pg/mL) compared to controls (254.5 ± 109.2 pg/mL).